Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers.

Abstract excerpt

Somatic mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene in lung cancers have generated enormous interest, because they predict for sensitivity to TK inhibitors (TKIs). While mutational status is of great importance in determining response to TKIs, it is not the sole factor, and evidence is accumulating that EGFR gene amplification, other members of the EGFR family...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Demography
• Share to Drug Resistance, Neoplasm
• Share to Enzyme Inhibitors